Home » Pall Corp. Acquires UK Chromatography Firm
Pall Corp. Acquires UK Chromatography Firm
01/26/2005
Pall Corporation (East Hills, N.Y.) announced January 25 that it has acquired Euroflow (UK) of Stroud, England. The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography columns and associated technologies since 2002. Euroflow sales are currently about $5 million a year.Pall also recently broadened its position in the chromatography market with its November 2004 acquisition of the BioSepra Process Division from Ciphergen Biosystems, Inc. Pall BioSepra develops, manufacturers and markets chromatography sorbents that greatly simplify protein purification for drug development and production. Both acquisitions target the rapidly growing biotechnology industry and allow Pall to provide a more complete "Total Fluid Management" systems approach to customers. The chromatography market represents about 40% of the total biotech industry potential for filtration and purification technologies.
Eric Krasnoff, Chairman and CEO of Pall Corporation, said, "We welcome Euroflow to our growing family of purification technologies. We are responding to the industry's request for integrated systems solutions for purification technologies from development through large-scale production. Pall's Total Fluid Management approach helps customers to consistently meet productivity, quality and regulatory requirements at the lowest cost of ownership."
More News:
- 03/18/2010 Teva Beats Out Pfizer & Activa in 3.5BN Rationpharm Generics DealFrom CTV.ca
- 03/18/2010 Johnson & Johnson CEO Weldon Gets 11% 2009 Raise, to $25.6MFrom AP.com
- 03/17/2010 $75 Million Drug Heist is Bitter Pill for LillyFrom IndyStar.com
- 03/17/2010 R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
- 03/15/2010 Diabetes Drug From Lilly, Amylin Under ScrutinyFrom Forbes.com
- 03/12/2010 AstraZeneca Inks First Generic Drugs DealFrom Business.timesonline.co.uk
- 03/12/2010 AstraZeneca Job Cuts Reflect New Landscape For Drug InnovationFrom FT.com
- 03/10/2010 Novartis Goes Wireless for Process and Plant Info
- 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
- 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
- All news »
- Popular Articles
- Newest Articles
- Popular Downloads
Get Connected Now!
- Featured White Papers

Print page